10 results on '"Frier, B. M."'
Search Results
2. Hypoglycaemia in adults with insulin-treated diabetes in the UK: self-reported frequency and effects.
- Author
-
Frier, B. M., Jensen, M. M., and Chubb, B. D.
- Subjects
- *
TYPE 2 diabetes diagnosis , *TYPE 1 diabetes , *EDUCATION , *GLYCOSYLATED hemoglobin , *HYPOGLYCEMIA , *INSULIN , *QUESTIONNAIRES , *RESEARCH funding , *SURVEYS , *BODY mass index , *INDEPENDENT living , *DISEASE duration , *SYMPTOMS , *DIAGNOSIS - Abstract
Aim Few real-life studies of non-severe (self-treated) hypoglycaemic events are available. This survey quantified the self-reported frequency of non-severe hypoglycaemia and its effects in adults with insulin-treated diabetes in the UK. Methods Adults aged > 15 years with Type 1 diabetes or insulin-treated Type 2 diabetes completed ≤ 4 weekly questionnaires (7-day recall). Respondents with Type 2 diabetes were grouped by insulin regimen: basal-only, basal-bolus and 'other'. Results Overall, 1038 respondents (466 with Type 1 diabetes, 572 with Type 2 diabetes) completed 3528 questionnaires. Mean numbers of non-severe events per week were 2.4 (Type 1 diabetes; median = 2) and 0.8 (Type 2 diabetes; median = 0); 23% and 26% of non-severe events occurred at night, respectively. Fatigue and reduced alertness were the commonest issues following events (78% and 51% of respondents, respectively). The effects of nocturnal events persisted longer than those of daytime events: Type 1 diabetes = 10.6 vs. 4.9 h ( P = 0.0002); Type 2 diabetes = 15.3 vs. 5.1 h ( P < 0.0001). In the week following an event, respondents' blood glucose measurements increased by 4.3 (Type 1 diabetes; 12% increment) and 4.2 (Type 2 diabetes; 21% increment) tests/week. In employed respondents, 20% of events caused work-time loss, more so following nocturnal (vs. daytime) hypoglycaemia: Type 1 diabetes = 2.7 vs. 1.1 h ( P = 0.0184); Type 2 diabetes = 2.5 vs. 1.6 h ( P = 0.1340). Most respondents rarely/never informed healthcare professionals about events (Type 1 diabetes = 82%, Type 2 diabetes = 69%). Conclusions Non-severe hypoglycaemia is common in adults with insulin-treated diabetes in the UK, with consequent health-related/economic effects. Communication about non-severe hypoglycaemia is limited and the burden of hypoglycaemia may be underestimated. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
3. Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources.
- Author
-
Heller, S. R., Frier, B. M., Hersløv, M. L., Gundgaard, J., and Gough, S. C. L.
- Subjects
- *
TREATMENT of diabetes , *TYPE 2 diabetes diagnosis , *TYPE 1 diabetes , *PEOPLE with diabetes , *HYPOGLYCEMIA , *INSULIN , *MEDICAL needs assessment , *MEDICAL care use , *RESEARCH funding , *DISEASE complications , *DIAGNOSIS - Abstract
Aims To assess resource utilization associated with severe hypoglycaemia across three insulin regimens in a large phase 3a clinical programme involving people with Type 1 diabetes treated with basal-bolus insulin, people with Type 2 diabetes treated with multiple daily injections and people with Type 2 diabetes treated with basal-oral therapy. Methods Data relating to severe hypoglycaemia events (defined as episodes requiring external assistance) from the insulin degludec and insulin degludec/insulin aspart programme (15 trials) were analysed using descriptive statistics. Comparators included insulin glargine, biphasic insulin aspart, insulin detemir and sitagliptin. Mealtime insulin aspart was used in some regimens. This analysis used the serious adverse events records, which documented the use of ambulance/emergency teams, a hospital/emergency room visit ≤ 24 h, or a hospital visit > 24 h. Results In total, 536 severe hypoglycaemia events were analysed, of which 157 (29.3%) involved an ambulance/emergency team, 64 (11.9%) led to hospital/emergency room attendance of ≤ 24 h and 36 (6.7%) required hospital admission (> 24 h). Although there were fewer events in people with Type 2 diabetes compared with Type 1 diabetes, once a severe episode occurred, the tendency to utilize healthcare resources was higher in Type 2 diabetes vs. Type 1 diabetes. A higher proportion (47.6%) in the basal-oral therapy group required hospital treatment for > 24 h versus the Type 1 diabetes (5.0%) and Type 2 diabetes multiple daily injections (5.3%) groups. Conclusion This analysis suggests that severe hypoglycaemia events often result in emergency/ambulance calls and hospital treatment, incurring a substantial health economic burden, and were associated with all insulin regimens. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
4. Hypoglycaemia symptoms and impaired awareness of hypoglycaemia in adults with Type 1 diabetes: the association with diabetes duration.
- Author
-
Olsen, S. E., Åsvold, B. O., Frier, B. M., Aune, S. E., Hansen, L. I., and Bjørgaas, M. R.
- Subjects
CONFIDENCE intervals ,PEOPLE with diabetes ,GLYCOSYLATED hemoglobin ,HYPOGLYCEMIA ,TYPE 1 diabetes ,QUESTIONNAIRES ,DATA analysis ,CROSS-sectional method ,DISEASE duration ,MANN Whitney U Test ,DISEASE complications ,SYMPTOMS ,DIAGNOSIS - Abstract
Aims To examine the association between diabetes duration and hypoglycaemia symptom profiles and the presence of impaired awareness of hypoglycaemia. Methods A cross-sectional study was performed, using validated methods for recording hypoglycaemia symptoms and assessing hypoglycaemia awareness. The associations between symptom intensity, hypoglycaemia awareness and diabetes duration were examined, and the prevalence of impaired awareness was ascertained for Type 1 diabetes of differing durations. Results Questionnaires were mailed to 636 adults with Type 1 diabetes, of whom 445 (70%) returned them. A total of 440 completed questionnaires were suitable for analysis. Longer diabetes duration was associated with lower intensity of autonomic symptoms ( P for trend <0.001), but no association was observed with neuroglycopenic symptoms. The overall prevalence of impaired awareness of hypoglycaemia in this cohort was 17% (95% CI 14-21%) and increased with diabetes duration, from 3% for duration 2-9 years to 28% for duration ≥30 years ( P for trend <0.001). Low autonomic symptom scores were not associated with a higher prevalence of impaired awareness. Conclusions Longer diabetes duration was associated with lower intensity of autonomic symptoms and a higher prevalence of impaired awareness of hypoglycaemia, suggesting that subjective symptoms of hypoglycaemia change over time. These observations underline the need for regular patient education about hypoglycaemia symptomatology and clinical screening for impaired awareness of hypoglycaemia. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
5. Severe hypoglycaemia and late-life cognitive ability in older people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
- Author
-
Aung, P. P., Strachan, M. W. J., Frier, B. M., Butcher, I., Deary, I. J., and Price, J. F.
- Subjects
TYPE 2 diabetes prevention ,DIABETIC retinopathy ,COGNITION ,DIABETES ,PEOPLE with diabetes ,GLYCOSYLATED hemoglobin ,HYPOGLYCEMIA ,TYPE 2 diabetes ,DATA analysis ,CROSS-sectional method ,DIAGNOSIS ,PREVENTION - Abstract
Diabet. Med. 29, 328-336 (2012) Abstract Objective To determine the association between lifetime severe hypoglycaemia and late-life cognitive ability in older people with Type 2 diabetes. Methods Cross-sectional, population-based study of 1066 men and women aged 60-75 years, with Type 2 diabetes. Frequency of severe hypoglycaemia over a person's lifetime and in the year prior to cognitive testing was assessed using a previously validated self-completion questionnaire. Results of age-sensitive neuropsychological tests were combined to derive a late-life general cognitive ability factor, ' g'. Vocabulary test scores, which are stable during ageing, were used to estimate early life (prior) cognitive ability. Results After age- and sex- adjustment, ' g' was lower in subjects reporting at least one prior severe hypoglycaemia episode ( n = 113), compared with those who did not report severe hypoglycaemia (mean ' g'−0.34 vs. 0.05, P < 0.001). Mean vocabulary test scores did not differ significantly between the two groups (30.2 vs. 31.0, P = 0.13). After adjustment for vocabulary, difference in ' g' between the groups persisted (means −0.25 vs. 0.04, P < 0.001), with the group with severe hypoglycaemia demonstrating poorer performance on tests of Verbal Fluency (34.5 vs. 37.3, P = 0.02), Digit Symbol Testing (45.9 vs. 49.9, P = 0.002), Letter-Number Sequencing (9.1 vs. 9.8, P = 0.005) and Trail Making ( P < 0.001). These associations persisted after adjustment for duration of diabetes, vascular disease and other potential confounders. Conclusions Self-reported history of severe hypoglycaemia was associated with poorer late-life cognitive ability in people with Type 2 diabetes. Persistence of this association after adjustment for estimated prior cognitive ability suggests that the association may be attributable, at least in part, to an effect of hypoglycaemia on age-related cognitive decline. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
6. The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review.
- Author
-
Barendse, S., Singh, H., Frier, B. M., and Speight, J.
- Subjects
QUALITY of life ,DIABETES ,PEOPLE with diabetes ,DIET ,MEDICAL care ,EVALUATION of medical care ,HYPOGLYCEMIA ,TYPE 2 diabetes ,PATIENTS ,ACTIVITIES of daily living ,SYMPTOMS ,PSYCHOLOGY ,DIAGNOSIS ,DISEASE risk factors - Abstract
Diabet. Med. 29, 293-302 (2012) Abstract As a common side effect of insulin treatment for diabetes, hypoglycaemia is a constant threat and can have far-reaching and potentially devastating consequences, including immediate physical injury as well as more pervasive cognitive, behavioural and emotional effects. Moreover, as a significant limiting factor in achieving optimal glycaemic control, exposure to hypoglycaemia can influence diabetes self-management. Although hypoglycaemia is known to occur in Type 2 diabetes, its morbidity and impact on the individual are not well recognized. The aim of the current review is to examine published evidence to achieve a synthesis of the scope and significance of the potential detriment caused by hypoglycaemia to individuals with Type 2 diabetes. The implications of these observations for treatment and research have also been considered. A narrative review was performed of empirical papers published in English since 1966, reporting the effect of hypoglycaemia on quality of life and related outcomes (including generic and diabetes-specific quality of life, emotional well-being and health utilities) in Type 2 diabetes. Research demonstrates the potential impact of hypoglycaemia on the lives of people with Type 2 diabetes, from an association with depressive symptoms and heightened anxiety, to impairment of the ability to drive, work and function in ways that are important for quality of life. Few studies consider hypoglycaemia as an explanatory variable in combination with quality of life or related primary endpoints. As a consequence, there is a pressing need for high-quality research into the overall impact of hypoglycaemia on the lives of people with Type 2 diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
7. Frequency of symptomatic and asymptomatic hypoglycaemia in Type 1 diabetes: effect of impaired awareness of hypoglycaemia.
- Author
-
Schopman, J. E., Geddes, J., and Frier, B. M.
- Subjects
DIABETES complications ,ANALYSIS of variance ,CHI-squared test ,COMPUTER software ,FISHER exact test ,HYPOGLYCEMIA ,MEDICAL self-examination ,STATISTICAL hypothesis testing ,T-test (Statistics) ,U-statistics ,DATA analysis ,DIAGNOSIS - Abstract
Aims To characterize the frequency and the nature (symptomatic vs. asymptomatic) of hypoglycaemia in people with Type 1 diabetes with impaired awareness of hypoglycaemia. Methods A group of 19 patients with Type 1 diabetes with normal hypoglycaemia awareness were matched for age, sex, duration of diabetes and glycaemic control with 19 patients with impaired awareness of hypoglycaemia. Frequency of severe hypoglycaemia in the preceding year was estimated retrospectively. Capillary blood glucose was monitored prospectively four times daily, over a 4-week period. All blood glucose values < 3 mmol / l were recorded and classified by symptom response. Results The patients with impaired awareness of hypoglycaemia exhibited twice the frequency of all episodes of hypoglycaemia over the 4-week monitoring period than those with normal awareness (mean ±
SD 7.9 ± 5.4 vs. 3.7 ± 3.6, P = 0.003). No differences between the two subgroups were observed in the total number of symptomatic hypoglycaemia episodes (4.2 ± 3.3 vs. 3.2 ± 3.4, P = 0.25). The group with impaired awareness of hypoglycaemia had a sevenfold higher incidence of asymptomatic hypoglycaemia than those with normal awareness (3.7 ± 5.3 vs. 0.5 ± 1.2, P = 0.001); these episodes comprised 47%of all glucose values < 3.0 mmol / l in this group, compared with 14% in the normal awareness group. The annual prevalence of severe hypoglycaemia for patients with impaired awareness of hypoglycaemia was 53% compared with 5%for patientswith normal awareness, and these patients had a significantly higher incidence of severe events (1.6 ± 2.8 vs. 0.1 ± 0.3, P = 0.001). Conclusions Adults with Type 1 diabetes who have impaired awareness of hypoglycaemia are exposed to a much higher incidence of asymptomatic hypoglycaemia than those with normal awareness and are at higher risk of developing severe hypoglycaemia. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
8. Symptoms of hypoglycaemia in people with diabetes.
- Author
-
McAulay, V., Deary, I. J., and Frier, B. M.
- Subjects
HYPOGLYCEMIA ,PEOPLE with diabetes ,DIAGNOSIS - Abstract
AbstractThe symptoms of hypoglycaemia are fundamental to the early detection and treatment of this side-effect of insulin and oral hypoglycaemic therapy in people with diabetes. The physiology of normal responses to hypoglycaemia is described and the importance of symptoms of hypoglycaemia is discussed in relation to the treatment of diabetes. The symptoms of hypoglycaemia are described in detail. The classification of symptoms is considered and the usefulness of autonomic and neuroglycopenic symptoms for detecting hypoglycaemia is discussed. The many external and internal factors involved in the perception of symptoms are reviewed, and symptoms of hypoglycaemia experienced by people with Type 2 diabetes are addressed. Age-specific differences in the symptoms of hypoglycaemia have been identified, and are important for clinical and research practice, particularly with respect to the development of acquired hypoglycaemia syndromes in people with Type 1 diabetes that can result in impaired awareness of hypoglycaemia. In addition, the routine assessment of hypoglycaemia symptoms in the diabetic clinic is emphasized as an important part of the regular review of people with diabetes who are treated with insulin. Diabet. Med. 18, 690–705 (2001). [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
9. Moderate hypoglycaemia obliterates working memory in humans with and without insulin treated diabetes.
- Author
-
Deary, I. J., Sommerfield, A. J., McAulay, V., and Frier, B. M.
- Subjects
SHORT-term memory ,HYPOGLYCEMIA ,INSULIN ,ENDOCRINE diseases ,PEOPLE with diabetes ,BLOOD sugar ,LEARNING ,NEUROPSYCHOLOGICAL tests ,TYPE 1 diabetes ,MEMORY ,PROBLEM solving ,PSYCHOLOGY ,DIAGNOSIS - Abstract
The article focuses on a study that examined the effect of moderate hypoglycaemia on working memory in humans with and without insulin treated diabetes. Working memory is a crucial cognitive process, necessary for many everyday tasks, but its integrity during hypoglycaemia is not known. Working memory performance was studied in 32 young adults. Sixteen (nine men, seven women) were healthy, non-diabetic subjects aged between 26 and 34 years (mean (SD), 29.6 (1.7) years); a further 16 (nine men, seven women) were otherwise healthy individuals with type 1 diabetes, aged between 20 and 38 years (28.5 (5.4) years).
- Published
- 2003
- Full Text
- View/download PDF
10. Does severe hypoglycaemia influence microvascular complications in Type 1 diabetes? An analysis of the Diabetes Control and Complications Trial database.
- Author
-
Kilpatrick, E. S., Rigby, A. S., Atkin, S. L., and Frier, B. M.
- Subjects
DIABETES prevention ,DIABETIC nephropathies ,DIABETIC retinopathy ,CAPILLARY permeability ,CONFIDENCE intervals ,EPIDEMIOLOGY ,GLYCOSYLATED hemoglobin ,HYPOGLYCEMIA ,TYPE 1 diabetes ,LOGISTIC regression analysis ,DATA analysis ,DISEASE complications ,DIAGNOSIS - Abstract
Diabet. Med. 29, 1195-1198 (2012) Abstract Aims Severe hypoglycaemia may have a role in aggravating micro- and macrovascular disease in diabetes. Data from the Diabetes Control and Complication Trial have been reanalysed to ascertain whether the frequency of severe hypoglycaemia exerted an influence on the development and progression of retinopathy or nephropathy in people with Type 1 diabetes. Methods Using binary longitudinal multiple logistic regression, HbA
1c at study baseline, mean HbA1c throughout the study and the number of severe hypoglycaemic episodes during the trial were compared to examine the risk of development/progression of retinopathy and nephropathy. Results Average HbA1c during the study and/or HbA1c at baseline were independently predictive of retinopathy and nephropathy both in the intensively and the conventionally treated patients (all P ≤ 0.001). However, the number of hypoglycaemic episodes did not add to HbA1c in predicting retinopathy [odds ratio (95% CI) 0.99 (0.96-1.01), P = 0.51 in intensively treated patients, 0.94 (0.89-1.00), P = 0.05, conventional] or nephropathy [odds ratio (95% CI) 0.98 (0.95-1.01), P = 0.48 intensive, 1.03 (0.98-1.10), P = 0.17 conventional]. Conclusions The frequency of exposure to severe hypoglycaemia did not predict a different risk of developing retinopathy or nephropathy in either treatment group of the Diabetes Control and Complications Trial at any given HbA1c . [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.